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Background
Economic outcomes are commonly evaluated along 
with clinical outcomes in health policy research. 
When published in business or economics sources, 
such articles may not be indexed in databases tra-
ditionally consulted for clinical systematic re-
views. The goal of this dual case study was to ex-
plore the significance of non-health sources, es-
pecially databases that index economic research, 
in comprehensive searching for a systematic 
review of health policy interventions.  
Methods 
We are performing case studies of two litera-
ture searches for systematic reviews of health 
policy interventions: one on Formulary-Based 
Drug Coverage Policies and one on Direct to 
Consumer Advertising of Pharmaceuticals.  
All citations retrieved for the reviews were 
tagged with their source(s) of origin (typically 
database name). Absolute number and per-
centage of relevant citations were tracked 
after the initial “weed,” after the full-text 
weed, and after the reviewers had assessed 
full-text articles for meeting review inclusion 
criteria. Citation sources were analyzed for 
number of results used in the review, number 
of unique results used in the review, and 
“missed” results (that turned up in another da-
tabase search and “should” have been dupli-
cated in that database as well).   
Results*
Results indicate that Medline and EMBASE, while 
highest in number of citations, had very few 
unique citations. Non-biomedical sources, such as 
economic and business databases, on the other 
hand, garnered relevant results not indexed in bio-
medical databases. Citation tracing garnered more 
unique results than any database.
Of the twelve articles included in the Formulary-
Based Drug Coverage Policies review, only three were 
unique to a particular database. Those databases were 
EconLit, ABI-Inform, and Digital Dissertations. Five ad-
ditional articles were uniquely identified through cita-
tion searching. The remaining four articles appeared in 
multiple data sources. 
While the Direct to Consumer Advertising systematic 
review has not yet undergone a final full-text weed, 
preliminary results indicate that a similar pattern is 
emerging, where the smaller, non-biomedical 
sources appear to be providing more unique, non-
duplicated citations.  
*Results at time of poster are incomplete and prelimi-
nary. Fuller results will be available as the second review 
is completed.
Discussion 
Large biomedical databases such as Medline 
and EMBASE, which are common first sources to 
consult in a health-related literature review, 
may not be as essential in identifying unique 
articles for systematic literature searching as 
smaller, niche databases in tangential fields, 
due to the large amount of duplication of con-
tent among the large, more comprehensive da-
tabases.  
Investigators seeking to complete a systematic 
review of health policy should consider the in-
clusion of non-biomedical databases, particu-
larly economic databases, in their search 
strategies. Citation tracing is reaffirmed as a 
critical element of the systematic review 
search process.
Key Messages
Large databases of the type that would be most 
useful for an initial literature search are not 
necessarily the most important in a systematic 
review, as they produced few, if any, unique cita-
tions.
Business and economics databases can provide ar-
ticles not indexed in traditional health or medical 
databases.
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*There are only 40 articles here because in two instances two articles drew on
the same research and were collapsed into one entry in this table.
Less than 1% 
of the original 
articles.
The only sources that were 
unique origins for included stud-
ies were ABI/Inform, EconLit, and 
citation searching/serendipity.  
As expected, MEDLINE, EMBASE, 
and IPA did contain a relatively 
large number of appropriate cita-
tions, but none were unique to 
one source.  
We failed to uncover a number of 
appropriate articles in MEDLINE 
and CINAHL in our initial 
searches, due to lack of familiar-
ity with some subject headings 
that are used in the US context of 
predominantly private health 
care. Through citation searching, 
we were able to identify terms to 
add to our search and then catch 
missed articles.  
Where were the 
articles from?
ABI/Inform - 37
CINAHL - 38
Digi Diss - 1
EBM - 336
EconLit - 53
EMBASE- 444
IPA - 113 
Medline - 89
PAIS - 5
WoS - 185
Where did the 
final review 
articles originate?
ABI/Inform – 1*
Digi Diss – 1*
EBM – 1
EconLit – 1*
EMBASE – 4
IPA –  3
Medline – 2
WoS – 1
Citation searching – 6 (5*)
*unique to that source
Formulary-
based policies
systematic
review
1301 titles
selected for
title review
384 titles (30%)
relevant for 
abstract review
(duplicates removed;
914 titles rejected)
59 titles
selected by
Reviewer 1
59 titles (15%)
requested for
full text screening
after R1 and R2
compared
72 titles
full text 
screened
65 titles
selected by
Reviewer 2
14 new articles 
from hand and 
citation searching
(1 not obtained)
42 titles
sent to
reviewers
12 titles
included 
in review
(84 unique)
